ESR1 and breast cancer: Similar transcriptomic analyses were performed by Xu and colleagues in a study of 360 Chinese patients with triple-negative breast cancer (TNBC), an aggressive breast cancer subtype that expresses low levels of ER, progesterone receptor (PR), and her2/neu [50].